PCSK9 inhibitor therapy: A systematic review and meta-analysis of metabolic and cardiovascular outcomes in patients with diabetes.

Matteo MonamiGiorgio SestiEdoardo Mannucci

Published in: Diabetes, obesity & metabolism (2018)

PCSK-9 inhibitors do not affect glucose metabolism. Their efficacy on LDL cholesterol and MACE in patients with diabetes does not seem to be very dissimilar to that observed in non-diabetic participants.

Keyphrases

low density lipoprotein
type diabetes
wound healing
stem cells